Compare ZGN & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZGN | CNMD |
|---|---|---|
| Founded | 1910 | 1970 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.2B |
| IPO Year | 2021 | 1995 |
| Metric | ZGN | CNMD |
|---|---|---|
| Price | $10.12 | $36.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | $11.28 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 697.1K | 374.4K |
| Earning Date | 03-20-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.43% | 1.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $1,374,724,000.00 |
| Revenue This Year | $5.12 | $0.82 |
| Revenue Next Year | $7.44 | $5.48 |
| P/E Ratio | $25.94 | ★ $23.87 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $6.13 | $35.37 |
| 52 Week High | $11.93 | $61.25 |
| Indicator | ZGN | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.10 | 32.27 |
| Support Level | $8.59 | $35.37 |
| Resistance Level | $10.73 | $46.08 |
| Average True Range (ATR) | 0.39 | 1.35 |
| MACD | -0.11 | -0.44 |
| Stochastic Oscillator | 45.37 | 12.38 |
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.